{"disease":{"id":"metrorrhagia","name":"metrorrhagia"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03230994","title":"Cooperative Adenomyosis Network","phase":"","overall_status":"UNKNOWN","enrollment_count":5000,"lead_sponsor_name":"Peking Union Medical College Hospital","has_results":false},{"nct_id":"NCT06802198","title":"A Randomized Study Comparing Subtotal vs Total Hysterectomy Long Term Outcomes","phase":"NA","overall_status":"NOT_YET_RECRUITING","enrollment_count":500,"lead_sponsor_name":"Fondazione Policlinico Universitario Agostino Gemelli IRCCS","has_results":false},{"nct_id":"NCT01918072","title":"Controlled Trial of Tele-Support and Education for Womens Health Care in CBOCs","phase":"","overall_status":"COMPLETED","enrollment_count":202,"lead_sponsor_name":"VA Office of Research and Development","has_results":true},{"nct_id":"NCT03121560","title":"Acceptability and Tolerance of Hysteroscopy and Hysterosonography in Consultation","phase":"NA","overall_status":"COMPLETED","enrollment_count":110,"lead_sponsor_name":"Brugmann University Hospital","has_results":false},{"nct_id":"NCT02824224","title":"Tamoxifen to Reduce Unscheduled Bleeding in New Users of the Levonorgestrel-releasing Intrauterine System (LNG-IUS)","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Oregon Health and Science University","has_results":true},{"nct_id":"NCT05406960","title":"Therapeutic Effect of Herbal Infusion on Menometrorrhagia","phase":"NA","overall_status":"COMPLETED","enrollment_count":13,"lead_sponsor_name":"Faculty of Medicine, Sousse","has_results":false},{"nct_id":"NCT01557023","title":"Clinical Trial With Combination of Dienogest/Ethytnilestradiol and Drosperidona/Ethyniestradiol","phase":"PHASE3","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"Eurofarma Laboratorios S.A.","has_results":false},{"nct_id":"NCT05538689","title":"Surgical Myomectomy Followed by Oral Myfembree Versus Standard of Care Trial (SOUL)","phase":"PHASE4","overall_status":"WITHDRAWN","enrollment_count":0,"lead_sponsor_name":"University of Chicago","has_results":false}],"total":8},"guidelines":[],"source":"Drug Landscape verified database"}